The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / IgG from Patients with Autoimmune Disease Activates Neutrophils

IgG from Patients with Autoimmune Disease Activates Neutrophils

March 18, 2019 • By Lara C. Pullen, PhD

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Abnormalities in neutrophil function play a role in autoimmune rheumatic diseases, such as systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). Data also suggest immunoglobulin G (IgG) may be important in immunopathology, thus, many researchers have sought to better understand the interaction between IgG and neutrophils.

You Might Also Like
  • Neutrophils & B Cells Create Unique Antibodies in Lupus Patients
  • Aggregated Neutrophils Limit Inflammation
  • Rheumatology Researchers Explore Role of Neutrophils in Autoimmunity
Also By This Author
  • Using the 2019 EULAR/ACR Classification Criteria to Predict Disease Severity in SLE

New data reveal a different pattern of neutrophil activation in SLE patients than in RA patients. Moreover, different autoimmune diseases have distinct patterns of IgG-mediated integrin activation and neutrophil function, which may explain disease-specific differences in vascular damage and dysfunction. Akif A. Khawaja, PhD, a research associate at University College, London, U.K., and colleagues say the research, published online in Scientific Reports, points toward novel approaches to develop new therapies.1

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The investigators isolated neutrophils from 12 healthy controls, 12 SLE patients and seven RA patients. They evaluated the differences between the isolated neutrophils of each group, finding that SLE neutrophils had significantly lower rates of hydrogen peroxide (H2O2) production than healthy control neutrophils and RA neutrophils. Additionally, they found IgG more readily bound the neutrophils of SLE and RA samples than it did the neutrophils of healthy controls. Having established the difference in binding, the investigators next sought to determine if IgG modulated β1 or β2 integrin-mediated adhesion.

“Our experiments utilized immobilized fibronectin and fibrinogen, which are found in areas of tissue injury with local activation of coagulation and in regions of vascular endothelial damage where the sub-endothelial basement membrane has been exposed,” write the authors in their discussion. “Our choice of ligands has the advantage of readily allowing us to distinguish the effects of IgG on β1-mediated adhesion to ECM/VCAM-1 from the effects on αMβ2-mediated adhesion.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The researchers found that, although both RA-IgG and SLE-IgG increased PMA-induced β1 integrin-mediated adhesion to fibronectin, only SLE-IgG enhanced αMβ2 integrin-mediated adhesion to fibrinogen.

Next, the researchers examined the modulatory effects of IgG samples from the different groups on unstimulated and PMA-induced adhesion to human umbilical cord endothelial cells. They found SLE IgG significantly enhanced both unstimulated and PMA-induced neutrophil adhesion to human umbilical cord endothelial cells.

“Integrin activation is central to leukocyte migration, therefore, we examined whether autoimmune rheumatic disease-IgG affected neutrophil adhesion to, and migration across, the endothelium,” write the authors. “Interestingly, SLE IgG, but not RA IgG, significantly augmented neutrophil adhesion to [human umbilical cord endothelial cells], while migration across an IL-8 gradient was unaffected by [autoimmune rheumatic disease]-IgG.”

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

The investigators then turned their attention to characterizing the ability of IgG to modulate the release of extracellular DNA and found both SLE and RA IgG caused unstimulated neutrophils to increase reactive oxygen species generation and DNA externalization. Specifically, neutrophils cultured in the presence of SLE or RA IgG spontaneously released more DNA than neutrophils cultured with healthy control IgG. However, co-culture with resting endothelium prevented IgG-mediated increase of extracellular DNA. That said, in the case of SLE IgG, the inhibition could be overcome by stimulating the endothelium with TNF-α.

Pages: 1 2 | Single Page

Filed Under: Uncategorized Tagged With: Autoimmune disease, human immunoglobulin G, immunoglobulin G (IgG), neutrophil, neutrophils

You Might Also Like:
  • Neutrophils & B Cells Create Unique Antibodies in Lupus Patients
  • Aggregated Neutrophils Limit Inflammation
  • Rheumatology Researchers Explore Role of Neutrophils in Autoimmunity
  • Immunotherapy Largely Untested in Patients with Autoimmune Disease

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.